AYX is my #1 holding so like many here I’ve been wondering what’s triggering AYX’s relative slump. Until CRWD’s ER I was also wondering about its underperformance relative to stocks we follow.
I’d love to hear thoughts on these 2 possibilities and outlooks…
(1) Unlike stocks like Okta, MDB or Coupa, do AYX and CRWD both suffer from a general disbelief in a long-term CAP? Aside from any daily TA patterns it seems like there is another cycle. After the glow of their incredible ER cools (usually a month or so), doubt seems to creep back in as analysts and industry experts question each firm’s ability to sustain growth among a landscape full of VC money and innovation. Prices slowly drift down, investor anxiety settles in and position-trimming adds more fuel to the pullback. AYX is not one to constantly release news so the void is filled by competitive updates or market deterioration concerns. Competitive news or market suppositions resonate more against AYX and CRWD than it does other stocks that appear to have stronger moats.
(2) Right now, without an obvious connection to supporting COVID efforts or WFM, AYX is now additionally weak from a concern about IT priorities shifting and budgets being diverted to support WFH solutions vs new AYX installs or licenses. I went searching on AYX’s website for any clues to ways they support Covid-fighting and found this: https://www.alteryx.com/input/to-our-customers.
In case you skip it, the article specifically highlights remote work capabilities with AYX and that AYX will be sharing new Covid-related use cases in April.
Outlooks:
My guess (I’m trying to brace myself for this anyway) is that AYX holders are not going to see much relief until we are close to the next ER when, barring general Covid-related market swings we get the usual movement up. It feels like the magnitude of the pre-ER rise will be more subdued if Covid issues are still front and centre and there have been no analyst commentaries on channel check progress.
I’m expecting AYX’s Q1 results to be affected by Covid, but that its focus on larger accounts helps buffer negative headwinds and it once again surprises on the upside of that very low guidance (maybe less upside than usual though).
CRWD, thanks to its role in supporting WFH and market tailwinds like Symantec’s partial market abandonment has an excellent chance of continued gains - avoiding its usual mid-cycle drop.
Soludag
Long AYX and CRWD